State Street Corp Boosts Stock Holdings in Electromed, Inc. (NYSE:ELMD)

State Street Corp boosted its position in Electromed, Inc. (NYSE:ELMD) by 14.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,066 shares of the company’s stock after purchasing an additional 2,800 shares during the period. State Street Corp’s holdings in Electromed were worth $474,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. Morgan Dempsey Capital Management LLC purchased a new position in shares of Electromed during the 2nd quarter worth approximately $108,000. Renaissance Technologies LLC grew its holdings in Electromed by 4.8% during the second quarter. Renaissance Technologies LLC now owns 103,004 shares of the company’s stock worth $1,548,000 after acquiring an additional 4,736 shares during the period. Pekin Hardy Strauss Inc. purchased a new position in Electromed in the second quarter worth $522,000. Gabelli Funds LLC lifted its holdings in Electromed by 7.8% in the second quarter. Gabelli Funds LLC now owns 38,675 shares of the company’s stock valued at $581,000 after acquiring an additional 2,808 shares during the period. Finally, Marshall Wace LLP purchased a new stake in shares of Electromed during the 2nd quarter worth $256,000. Hedge funds and other institutional investors own 40.82% of the company’s stock.

Insider Buying and Selling

In other Electromed news, Director Andrew Summers sold 12,731 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $29.98, for a total transaction of $381,675.38. Following the completion of the transaction, the director now directly owns 165,755 shares in the company, valued at approximately $4,969,334.90. This trade represents a 7.13 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 14.00% of the company’s stock.

Electromed Stock Up 2.0 %

NYSE:ELMD opened at $30.69 on Friday. Electromed, Inc. has a fifty-two week low of $9.81 and a fifty-two week high of $31.31. The firm’s fifty day simple moving average is $27.91 and its 200-day simple moving average is $21.01. The stock has a market cap of $259.58 million, a PE ratio of 42.63 and a beta of 0.31.

Electromed (NYSE:ELMD) last issued its earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.13. Electromed had a net margin of 11.34% and a return on equity of 15.32%. The company had revenue of $14.67 million for the quarter.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.